This move is archived. Current quotes and coverage live on the stock page.
Follow NRX
NurExone Biologic Inc. is having a good trading day, with shares steadily rising.
NurExone Biologic Inc. (NRX.V) is up today, showing a 1.92% increase in its stock price. The company's market cap is around CA$54.3 million, indicating growing interest from investors.
Advertisement
NurExone Biologic Inc.
NRX.V
NRX.V
NurExone Biologic Inc.
WealthAwesomeMarket cap
$61.67M
52W high
$1.09
52W low
$0.43
1W change
-9.38%
Beta
0.45
Analyst Price Targets
Based on analyst covering NRX · as of Sep 17, 2026
Wall Street analysts forecast NRX stock price to rise 329.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$2.49
+329.5% Upside
Current Price
C$0.58
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on NRX's historical volatility
30-Day Vol
137.5%
Annualized
90-Day Vol
88.8%
Annualized
Trend (90d)
+14.7%
Annualized drift
90d Mean
C$0.61
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.59 | C$0.37 – C$0.95 |
| 60 trading days | C$0.60 | C$0.31 – C$1.17 |
| 90 trading days | C$0.61 | C$0.27 – C$1.39 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: The rise in NurExone's stock could signal potential growth, especially considering the company's recent updates and financial results.
NurExone's stock price rises to CA$0.53
The stock's increase today puts it in a strong position in the market, which may attract more investor interest.
Bull case
The stock's upward trend might reflect investor confidence, particularly after recent updates that showcase strategic partnerships and positive financial results.
Bear case
Despite the positive movement, the lack of significant news or catalysts today could lead to fluctuations in the stock's performance.
Stock Performance Overview
Advertisement
NurExone Biologic Inc. is on the rise today, with its stock price up by 1.92% to CA$0.53. This trend shows positive sentiment among investors, likely influenced by the company's recent updates.
Investor Sentiment and Market Trends
The increase in NurExone's stock today may suggest growing investor confidence. With a market cap of CA$54.3 million, the company is still in a developmental phase, which can attract risk-tolerant investors looking for growth opportunities. However, the lack of significant news today might lead to more cautious trading.
Looking Ahead
As NurExone Biologic Inc. continues to pursue its corporate strategies and financial goals, investors will be closely watching for any developments that could further impact its stock performance. The recent gains might be a sign of more substantial growth if the company can maintain its current momentum.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
